WebsiteGear Logo Log In
New User? Sign Up
About | Contact | FAQ
  Home News Technology Software Products Tuesday, October 23, 2018 
Add Press Release News | News Feeds Feeds | Email This News Email

Aortic Stenosis Epidemiology Forecast In 25 Major Markets 2018-2028: Risk Factors, Aetiology, Disease Diagnosis and Prognosis Along with Specific Variations by Geography and Ethnicity
Friday, August 10, 2018

DUBLIN, Aug. 10, 2018 /PRNewswire/ --

The "Aortic Stenosis Forecast In 25 Major Markets 2018-2028" report has been added to's offering.

Aortic Stenosis (AS) is the occlusion or loss of aortic valve surface area resulting in stenosis of the aortic valve. Currently, AS is thought to be the most common form of valvular heart disease in Western countries.

This report provides the current prevalent population for AS across 25 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Poland, Netherlands, Norway, Sweden, Denmark, Finland, Iceland, Ireland, Russia, Turkey, Japan, China, South Korea, India, Australia, Brazil, Mexico, Argentina) split by gender and 5-year age cohort. Along with the current prevalence, the report provides an overview of the risk factors, aetiology, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team, several of the main symptoms and co-morbidities of AS have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for AS include:

    --  Previous myocardial infarct / Angina
    --  Carotid atherosclerosis
    --  COPD
    --  Lower limb atherosclerosis
    --  Atrial fibrillation

    --  Heart failure

Reasons to buy

    --  Ability to quantify patient populations in global AS market to target
        the development of future products, pricing strategies and launch plans.
    --  Further insight into the prevalence of the subdivided types of AS and
        identification of patient segments with high potential.
    --  Delivery of more accurate information for clinical trials in study
        sizing and realistic patient recruitment for various countries.
    --  Better understanding on the impact of specific co-morbid conditions on
        the prevalent population of AS patients.
    --  Identification of AS patient sub-populations that require treatment.
    --  Better understanding of the specific markets that have the largest
        number of AS patients.

Key Topics Covered

    1. List Of Tables And Figures
    2. Introduction
    3. Cause Of The Disease
    4. Risk Factors & Prevention
    5. Diagnosis Of The Disease
    6. Variation By Geography/Ethnicity
    7. Disease Prognosis & Clinical Course
    8. Management Of Aortic Valve Stenosis
    9. Key Comorbid Conditions / Features Associated With The Disease
    10. Methodology For Quantification Of Patient Numbers
    11. Additional Data
    12. Top-Line Prevalence For Aortic Stenosis
    13. Features Of Aortic Stenosis Patients
    14. Mild Aortic Stenosis
    15. Moderate Aortic Stenosis
    16. Severe Aortic Stenosis
    17. Symptomatic
    18. Asymptomatic
    19. Comorbidities Of Aortic Stenosis Patients
    20. Moderate Aortic Stenosis
    21. Severe Aortic Stenosis
    22. Symptomatic
    23. Asymptomatic
    24. Abbreviations Used In The Report
    25. Other Publisher Services & Solutions
    26. Reports & Publications
    27. Online Epidemiology Databases
    28. Online Pharmaceutical Pricing Database
    29. References

    30. Appendix

For more information about this report visit

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

Media Contact:

Research and Markets
Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:

SOURCE Research and Markets

Email This News Email | Submit To Slashdot Slashdot | Submit To Digg | Submit To | News Feeds Feeds

Nav Hexagon Strengthens its Construction Solutions Portfolio for AEC (Architecture, Engineering, Construction) Market with Bricsys Acquisition | Oct 23, 2018
Nav Beijer Electronics Launches iX 2.40 SP1 - Taking EXTER and E1000 Applications to the Next Level | Oct 23, 2018
Nav GenomOncology announces GO Pathology Workbench in use by Emory Healthcare for Clinical Reporting | Oct 23, 2018
Nav Codewise Presents Revolutionary Traffic Distribution Automation Technology | Oct 23, 2018
Nav MetTel Wins Timmy Award for Best Tech Workplace for Diversity | Oct 23, 2018
Nav Epson Introduces WorkForce Pro WF-C500R Series with Replaceable Ink Pack System and Epson Print Admin Software Solution | Oct 23, 2018
Nav Airbiquity to Sponsor escar Europe 2018: World's Leading Automotive Cybersecurity Conference | Oct 23, 2018
Nav Global fixed broadband subscribers exceed one billion | Oct 23, 2018
Nav SAPĀ® Leonardo Unveils Latest Machine Learning and Analytics Updates | Oct 23, 2018
Nav Kinesis Money Partners With TicketSocket for Real-World Application of Gold-Based Currencies | Oct 23, 2018

Submit News | View More News View More News